Skip to main content
. 2022 Nov 25;14(23):5807. doi: 10.3390/cancers14235807

Figure 3.

Figure 3

The performance of MibcMLP in predicting prognosis in the external validation set. (A) univariate Cox and (B) multivariate Cox analyses are exhibited. Using the median risk score in the training set as the cut-off point, (C) K-M survival curves for the entire external validation set and the following subgroups: (D) age ≥70; (E) male; (F) pT stage 3–4; (G) pN stage 0–1; (H) pM stage 0; (I) pTNM stage 3–4; (J) lymphovascular invasion; (K) tumor size <5cm; (L) high histologic grade. ***, p < 0.001; **, p < 0.01; *, p < 0.05.